Hot Posts191- Page

Alumis Inc. (Nasdaq: ALMS), a clinical-stage biopharmaceutical company developing next-generation targeted therapies for patients with immune-mediated diseases, announced the closing of an upsized underwritten public offering of shares of its

Oak Hill Advisors (OHA) served as administrative agent and lead left arranger for a private unitranche financing supporting Majesco’s acquisition of Vitech Systems Group (Vitech) and a concurrent refinancing. Majesco,

Herbert Smith Freehills Kramer (HSF Kramer) is pleased to have advised Seven West Media Limited (ASX: SWM) (Seven) on the successful implementation of its combination with Southern Cross Media Group

Latham & Watkins has advised Shorooq Partners (Shorooq), a leading alternative investment manager in the MENA region, on the first US$22 million asset-backed financing for Flooss, an instant Sharia-compliant financing

Global law firm Clifford Chance has advised Generali on the corporate reorganisation of its group in Spain and Portugal following the acquisition of Liberty Seguros. The reorganisation was implemented, among

Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, has announced that it has repaid in full its existing senior secured loan from Oaktree Capital Management,

Global law firm Clifford Chance has advised the joint sponsors CICC and Huatai Financial Holdings (Hong Kong) Limited and underwriters on the initial public offering and listing of GigaDevice Semiconductor’s

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) has announced the pricing of its concurrent public offerings of (i) US$625 million aggregate principal amount of 0.00% convertible senior notes due 2032 (the notes)